423 related articles for article (PubMed ID: 23139286)
1. Cardiorenal syndrome: the emerging role of protein-bound uremic toxins.
Lekawanvijit S; Kompa AR; Wang BH; Kelly DJ; Krum H
Circ Res; 2012 Nov; 111(11):1470-83. PubMed ID: 23139286
[TBL] [Abstract][Full Text] [Related]
2. Cardiorenal syndrome: role of protein-bound uremic toxins.
Lekawanvijit S; Krum H
J Ren Nutr; 2015 Mar; 25(2):149-54. PubMed ID: 25556308
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanisms of protein-bound uremic toxin-mediated cardiac, renal and vascular effects: underpinning intracellular targets for cardiorenal syndrome therapy.
Savira F; Magaye R; Hua Y; Liew D; Kaye D; Marwick T; Wang BH
Toxicol Lett; 2019 Jun; 308():34-49. PubMed ID: 30872129
[TBL] [Abstract][Full Text] [Related]
4. Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome.
Lekawanvijit S; Kompa AR; Krum H
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F52-62. PubMed ID: 27147674
[TBL] [Abstract][Full Text] [Related]
5. Role of oxidative stress and indoxyl sulfate in progression of cardiovascular disease in chronic kidney disease.
Fujii H; Nakai K; Fukagawa M
Ther Apher Dial; 2011 Apr; 15(2):125-8. PubMed ID: 21426501
[TBL] [Abstract][Full Text] [Related]
6. Cardiorenal syndrome: pathophysiological mechanism, preclinical models, novel contributors and potential therapies.
Fu Q; Cao L; Li H; Wang B; Li Z
Chin Med J (Engl); 2014; 127(16):3011-8. PubMed ID: 25131243
[TBL] [Abstract][Full Text] [Related]
7. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients.
Ito S; Yoshida M
Toxins (Basel); 2014 Feb; 6(2):665-78. PubMed ID: 24561478
[TBL] [Abstract][Full Text] [Related]
8. Impacts of Indoxyl Sulfate and p-Cresol Sulfate on Chronic Kidney Disease and Mitigating Effects of AST-120.
Liu WC; Tomino Y; Lu KC
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30208594
[TBL] [Abstract][Full Text] [Related]
9. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
Niwa T
Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
[TBL] [Abstract][Full Text] [Related]
10. Update of uremic toxin research by mass spectrometry.
Niwa T
Mass Spectrom Rev; 2011; 30(3):510-21. PubMed ID: 21328600
[TBL] [Abstract][Full Text] [Related]
11. Role of Gut-Derived Protein-Bound Uremic Toxins in Cardiorenal Syndrome and Potential Treatment Modalities.
Lekawanvijit S
Circ J; 2015; 79(10):2088-97. PubMed ID: 26346172
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein-bound uremic toxins in chronic kidney disease.
Niwa T
Expert Opin Ther Targets; 2013 Nov; 17(11):1287-301. PubMed ID: 23941498
[TBL] [Abstract][Full Text] [Related]
13. Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.
Sato E; Saigusa D; Mishima E; Uchida T; Miura D; Morikawa-Ichinose T; Kisu K; Sekimoto A; Saito R; Oe Y; Matsumoto Y; Tomioka Y; Mori T; Takahashi N; Sato H; Abe T; Niwa T; Ito S
Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29283413
[TBL] [Abstract][Full Text] [Related]
14. Uremic toxicity of indoxyl sulfate.
Niwa T
Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
[TBL] [Abstract][Full Text] [Related]
15. Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome.
Lekawanvijit S
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30200452
[TBL] [Abstract][Full Text] [Related]
16. Vasculopathy in the setting of cardiorenal syndrome: roles of protein-bound uremic toxins.
Guo J; Lu L; Hua Y; Huang K; Wang I; Huang L; Fu Q; Chen A; Chan P; Fan H; Liu ZM; Wang BH
Am J Physiol Heart Circ Physiol; 2017 Jul; 313(1):H1-H13. PubMed ID: 28411233
[TBL] [Abstract][Full Text] [Related]
17. [The uremic toxin, indoxyl sulfate, signifies cardio-renal risk and intestinal-renal relationship].
Kiss I
Orv Hetil; 2011 Oct; 152(43):1724-30. PubMed ID: 21983398
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis signal-regulating kinase 1 inhibition attenuates cardiac hypertrophy and cardiorenal fibrosis induced by uremic toxins: Implications for cardiorenal syndrome.
Savira F; Cao L; Wang I; Yang W; Huang K; Hua Y; Jucker BM; Willette RN; Huang L; Krum H; Li Z; Fu Q; Wang BH
PLoS One; 2017; 12(11):e0187459. PubMed ID: 29107962
[TBL] [Abstract][Full Text] [Related]
19. P
Kamprom W; Tawonsawatruk T; Mas-Oodi S; Anansilp K; Rattanasompattikul M; Supokawej A
Int J Med Sci; 2021; 18(3):744-755. PubMed ID: 33437209
[TBL] [Abstract][Full Text] [Related]
20. An oral adsorbent, AST-120, suppresses oxidative stress in uremic rats.
Nakagawa N; Hasebe N; Sumitomo K; Fujino T; Fukuzawa J; Hirayama T; Kikuchi K
Am J Nephrol; 2006; 26(5):455-61. PubMed ID: 17057375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
